BP has announced that it intends to carry out a share repurchase, or buy-back, programme with a total value of up to $8bn.
HSBC takes a stab at wacky correlations between the performance of the 28 teams taking part in Hong Kong's most celebrated annual three-day sporting event, the Hong Kong Rugby Sevens, and economic trends.
US authorities have charged the brother of fallen hedge fund billionaire Raj Rajaratnam with participating in his insider dealing scam.
Increasing the level of fines on highly profitable financial institutions will not alter their behaviour, the head of the Financial Conduct Authority said on Thursday as he set out his vision for the new regulator.
Cyprus' finance minister is returning to Cyprus from Russia after two days of talks with officials which failed to deliver a deal to rescue Cyprus.
Sir John Peace really should know better. He is the chairman of a bank, Standard Chartered, that has admitted responsibility for breaching US sanctions against Iran and agreed to pay huge fines.
The reason a rescue agreement for Cyprus has been so difficult is "no one wants to bail out a bunch of Russian criminals," Bill Browder of Hermitage Capital told CNBC.
The head of fashion chain Next has blamed "incompetent" local councils, who are resistant to change for the grim state of some of the country's high streets, as he revealed "quiet" trading since January.
The economic malaise afflicting the eurozone deepened in March after figures for activity across all major industries declined, a survey showed on Thursday.
Rosneft has taken over TNK-BP in a $55bn (£36bn) deal that will make the Russian state-owned oil company by far the world's largest listed oil producer.
Quintain Estates and Development, the developer behind Wembley Arena, has been bought by US private equity group Lone Star for £700m.
Nearly two-thirds of companies face "significant" cyberattacks on a daily or weekly basis, according to an Accenture survey of senior executives across the globe.
The GlaxoSmithKline CEO, Sir Andrew Witty, said the Chinese drug market has slowed down dramatically over the past year but insisted that the drugmaker’s own business is stabilising, as it unveiled second-quarter results that beat City expectations.